Combining Engineered U1 snRNA and Antisense Oligonucleotides to Improve the Treatment of a BBS1 Splice Site Mutation
Breuel S, Vorm M, Bräuer AU, Owczarek-Lipska M, Neidhardt J. Mol Ther Nucleic Acids. 2019 Aug 16;18:123-130. PubMed
Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide
Kourkouta E, Weij R, GonzĂ¡lez-Barriga A, Mulder M, Verheul R, Bosgra S, Groenendaal B, Puoliväli J, Toivanen J, van Deutekom JCT, Datson NA. Mol Ther Nucleic Acids. 2019 Sep 6;17:601-614. PubMed
CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation
Tuladhar R, Yeu Y, Tyler Piazza J, Tan Z, Rene Clemenceau J, Wu X, Barrett Q, Herbert J, Mathews DH, Kim J, Hyun Hwang T, Lum L. Nat Commun. 2019 Sep 6;10(1):4056. PubMed
CRISPR DNA base editors with reduced RNA off-target and self-editing activities
GrĂ¼newald J, Zhou R, Iyer S, Lareau CA, Garcia SP, Aryee MJ, Joung JK. Nat Biotechnol. 2019 Sep;37(9):1041-1048. PubMed
Click-Particle Display for Base-Modified Aptamer Discovery
Gordon CKL, Wu D, Pusuluri A, Feagin TA, Csordas AT, Eisenstein MS, Hawker CJ, Niu J, Soh HT. ACS Chem Biol. 2019 Sep 18. PubMed
Massively parallel RNA device engineering in mammalian cells with RNA-Seq
Xiang JS, Kaplan M, Dykstra P, Hinks M, McKeague M, Smolke CD. Nat Commun. 2019 Sep 23;10(1):4327. PubMed
An in Vivo miRNA Delivery System for Restoring Infarcted Myocardium
Yang H, Qin X, Wang H, Zhao X, Liu Y, Wo HT, Liu C, Nishiga M, Chen H, Ge J, Sayed N, Abilez OJ, Ding D, Heilshorn SC, Li K. ACS Nano. 2019 Jun 7. PubMed
Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice
Klein AF, Varela MA, Arandel L, Holland A, Naouar N, Arzumanov A, Seoane D, Revillod L, Bassez G, Ferry A, Jauvin D, Gourdon G, Puymirat J, Gait MJ, Furling D, Wood MJA. J Clin Invest. 2019 Sep 3. PubMed
Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60-70 years
Hyer RN, Janssen RS. Vaccine. 2019 Sep 16;37(39):5854-5861. PubMed
Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
Miao L, Li L, Huang Y, Delcassian D, Chahal J, Han J, Shi Y, Sadtler K, Gao W, Lin J, Doloff JC, Langer R, Anderson DG. Nat Biotechnol. 2019 Sep 30. PubMed